Henry Schein, Inc. (HSIC) 股票分析

公司概述

Henry Schein, Inc. operates as a global distributor of healthcare products and services specifically tailored for office-based dental and medical practitioners. The company functions within the broader Healthcare sector, focusing on the specialized niche of Medical Distribution where it facilitates the supply chain between manufacturers and independent providers. This entity manages a substantial operational footprint with a market capitalization of $8.68B and annual revenue reaching $13.18B over the trailing twelve months. With an employee base of 25,000, the firm's scale indicates a significant position in the market, supported by diverse segments including Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology.

财务健康

The company reported a total revenue of $13.18B, net income of $398.00M, and EBITDA of $1.02B for the trailing twelve months. The substantial gap between the $13.18B in revenue and the $398.00M in net income reveals a cost structure heavily influenced by distribution expenses and operating costs typical of the medical supply industry. Free cash flow stands at $383.00M, which provides the company with significant financial flexibility to fund operations or manage capital expenditures without relying on external financing. Profitability is reflected across three key margins: a gross margin of 31.1%, an operating margin of 5.3%, and a profit margin of 3.0%. These margin levels indicate that while the company maintains healthy pricing power on its products, the operational model incurs significant costs that compress net profitability relative to sales. On the balance sheet, total cash holdings of $156.00M are contrasted against total debt of $3.44B, resulting in a debt-to-equity ratio of 71.74%. This leverage suggests the company utilizes debt financing, though the specific risk profile depends on the cost of debt relative to returns. Short-term liquidity is assessed via a current ratio of 1.38, indicating that the company holds sufficient current assets to cover its short-term liabilities with a modest buffer. Return on equity is 8.7% and return on assets is 4.3%, metrics that reveal the effectiveness of management in generating returns from shareholders' equity and the overall asset base, respectively.

估值评估

Valuation metrics show a trailing P/E ratio of 23.13 and a forward P/E of 12.87. The notable difference between these two figures implies that the market expects earnings to grow significantly in the future, as the forward multiple is substantially lower than the trailing multiple. The price-to-book ratio is 2.70, which indicates that the market values the company at a premium of 2.7 times its tangible book value. Alternative valuation measures include a price-to-sales ratio of 0.66 and an EV/EBITDA of 13.20, suggesting the stock is priced at a fraction of its sales while generating robust earnings relative to enterprise value. The stock price has traded between a 52-week low of $60.56 and a 52-week high of $89.29. Without the specific current share price, the exact percentage deviation from the high cannot be calculated, but the range defines the historical volatility envelope for the asset. The beta value is 0.88, indicating that the stock's price volatility is slightly lower than the broader market benchmark, suggesting a slightly defensive characteristic relative to the overall equity market.

Growth & Income

Revenue growth year-over-year is recorded at 7.7%, while earnings growth year-over-year reaches 13.6%. The fact that earnings are growing at a rate more than double the revenue growth implies that the company is becoming more efficient or benefiting from pricing power that expands margins faster than top-line sales. Regarding income distribution, the dividend yield is listed as N/A and the payout ratio is 0.0%. This indicates the company does not currently distribute dividends to shareholders but instead reinvests all earnings back into the business to fuel organic growth and expansion initiatives. Consequently, the overall growth and income profile is characterized by capital appreciation potential through retained earnings rather than current income generation via dividends.